FEBS Letters has retracted three papers by the Brazilian diabetologist Mario Saad, bringing his total to 18.
The now-retracted articles, published between 2005 and 2010, contain doctored images, according to the notices, which read similarly.
Here’s one, for the 2005 paper “Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals”: Continue reading Three more retractions brings diabetes researcher who once sued publishers to 18
Welcome to the Top 10, Fazlul Sarkar.
Sarkar, the cancer researcher formerly of Wayne State University who once tried to sue critics on PubPeer, has had another seven papers retracted. That makes a total of 40, and places him in the Top 10 of our leaderboard of authors with the most retractions.
Three of the retractions appear in Molecular Cancer Therapeutics and four are from PLOS ONE. All involve falsification of data; one article had been corrected earlier, in 2014. Continue reading Cancer researcher who once tried to sue critics is up to 40 retracted papers
A cancer researcher who went to court — unsuccessfully — claiming that commenters on PubPeer had cost him a new job has just lost another 12 papers.
The twelve now-retracted papers by Fazlul Sarkar and colleagues — as well as another by Sarkar that is now subject to an editor’s note — all appeared in Cancer Research, which made for a long table of contents in its September 15 issue. Continue reading Researcher who once tried to sue critics has another dozen papers retracted
Journals have retracted all but 19 of the 313 tainted papers linked to three of the most notorious fraudsters in science, with only stragglers left in the literature. But editors and publishers have been less diligent when it comes to delivering optimal retraction notices for the affected articles.
That’s the verdict of a new analysis in the journal Anaesthesia, which found that 15% of retraction notices for the affected papers fail fully to meet standards from the Committee for Publication Ethics (COPE). Many lacked appropriate language and requisite watermarks stating that the articles had been removed, and some have vanished from the literature.
The article was written by U. M. McHugh, of University Hospital in Galway, Ireland, and Steven Yentis, a consultant anaesthetist at Chelsea & Westminster Hospital in London. Yentis was editor of Anaesthesia during the three scandals and had a first-hand view of two of the investigations. He also is the editor who unleashed anesthetist and self-trained statistician John Carlisle on the Fujii papers to see how likely the Japanese researcher’s data were to be valid (answer: not very likely). Continue reading When it comes to retracting papers by the world’s most prolific scientific fraudsters, journals have room for improvement
Ulrich Lichtenthaler, a management professor who has had to retract 16 papers for data irregularities, has a new position in academia.
According to a news release from the International School of Management (ISM), a business school based in Germany, Lichtenthaler has been appointed Professor of Business Management and Entrepreneurship at the Cologne campus. Lichtenthaler is also taking over as one of the directors of the Entrepreneurship Institute at ISM, which conducts research in the field.
Lichtenthaler’s name may be familiar to readers: After journals retracted more than a dozen of his articles, he resigned from a previous post at the University of Mannheim in 2015.
We emailed Lichtenthaler to ask if he had disclosed his history to his new employers; he forwarded the email to ISM’s head of marketing and sales, who told us:
Continue reading Management researcher with 16 retractions has new professorship
The Lancet chapter of the Paolo Macchiarini saga appears to finally be over.
In an editorial titled “The final verdict on Paolo Macchiarini: guilty of misconduct,” the editors of the journal announce that they are retracting two papers by the now-disgraced surgeon and colleagues “after receiving requests to do so from the new President of the Karolinska Institute (KI), Ole Petter Ottersen.” Late last month, Ottersen declared Macchiarini and six other researchers — including one of the whistleblowers in the case — guilty of misconduct.
The long story took many twists and turns — for instance, in September 2015, Lancet editors wrote an editorial with close to the opposite title: “Paolo Macchiarini is not guilty of scientific misconduct,” published after KI released the results of a previous investigation: Continue reading “The final verdict:” Lancet retracts two papers by Macchiarini
Former super-star surgeon Paolo Macchiarini is guilty of misconduct, along with six of his co-authors — including one who initially help alert authorities to problems with Macchiarini’s work, according to an announcement today by his former institution, the Karolinska Institute.
KI is also calling to retract six articles co-authored by Macchiarini and his colleagues, including two highly cited papers in The Lancet. The papers described the procedure and outcomes of transplanting synthetic tracheas into three patients between 2011 and 2013.
KI’s investigation uncovered “serious inaccuracies and misleading information in the reviewed articles:”
Continue reading Karolinska finds Macchiarini, six other researchers guilty of misconduct
In 2012, investigations found that researcher Yoshitaka Fujii had fabricated well in excess of 100 papers, and recommended scores of retractions. Yet years later, publishers are still cleaning the literature of his problematic work.
For anyone not familiar the Fujii case: After researchers raised concerns about Fujii’s work, an anesthesiologist used statistical tools to determine the odds the results were likely to have come from actual experiments. The answer: infinitesimally small. (For more on Fujii’s “dramatic fall from grace,” check out this in-depth Nautilus article published by our co-founders in 2015.)
Over the last several months, four journals — three published by Elsevier, one by Springer — have retracted 21 papers by Fujii. Seventeen retractions stem from one journal — Clinical Therapeutics.
Twelve of the retractions are accompanied by the following text: Continue reading What took more than five years? Elsevier retracts 20 papers by world’s most prolific fraudster
What Caught Our Attention: We haven’t heard much about Bharat Aggarwal since his seven retractions in 2016 propelled him onto our leaderboard (and long after he threatened to sue Retraction Watch for our reporting). There was a whisper of a mention, when his name was listed as one of the organizers of a cancer conference from which MD Anderson (his former employer) had to publicly distance themselves as a co-sponsor. Continue reading Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions
2) Sensitization of squamous cell carcinoma to cisplatin induced killing by natural agents
What Caught Our Attention: Regular readers will be familiar with the saga involving Fazlul Sarkar and PubPeer: In 2014, Sarkar sued anonymous commenters on the site, claiming defamation (and that damaging comments may have cost him a new job). Although Sarkar won an initial ruling, it was overturned by an appeals court. In the midst of that, the ACLU (which represented PubPeer in the case) released a copy of a misconduct investigation report compiled by Sarkar’s institution, Wayne State University, which concluded that he had committed enough misconduct to warrant retracting 40 papers. The two latest notices, both of which cite Wayne State’s investigation, bring Sarkar’s total to 21. Continue reading Caught Our Notice: Researcher who sued PubPeer commenter up to 21 retractions
